Skip to content

HemaSure

by Mawi DNA Technologies, LLC 4 variants

Ref HemaSure-OMICS-3

HemaSure-OMICS-3 is an in vitro diagnostic device (EU IVDD general IVD; EMDN category venous or arterious blood collection devices) made by Mawi DNA Technologies, LLC, registered in EUDAMED on 13 Apr 2023 (Basic UDI-DI B-00850040712186), active as of 23 Oct 2026.

Active European Union

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-00850040712186 Basic UDI-DI 00850040712186UDI-DIDate13 Apr 2023RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Device name
HemaSure-OMICS Blood Stabilization Direct Draw device, 3ml
Model / reference
HemaSure-OMICS-3
Primary DI / UDI-DI
00850040712186
Basic UDI-DI
B-00850040712186
EMDN code
W0501010199 Venous or arterious blood collection devices - other
Device class
Class IVD General
EU registration type
Legacy device (under a directive)
EU market of registration
Northern Ireland

Manufacturer details

EUDAMED SRN
US-MF-000023207
Authorised representative
CEpartner4U NL-AR-000000111

Similar devices in this category

Other devices filed under VENOUS OR ARTERIOUS BLOOD COLLECTION DEVICES - OTHER.

Other devices from Mawi DNA Technologies, LLC

See all devices from Mawi DNA Technologies, LLC →

Properties

  • Supplied sterile
  • IVD kit
  • Professional testing
Other properties (9, all answered No)